SETDB1 and cancer: SETDB1 expression was evaluated in primary and metastatic cell line pairs of HNC by qRT-PCR and western blotting because dysregulation of SETDB1 is critical for different signaling pathways and has been suspected to stimulate cancer phenotypes (Richter et al., 2009; Sun et al., 2014; Sun et al., 2015).